Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury

  • Post author:
  • Post category:

Research Objective The objective of the proposed studies is to determine which of our excipient components are necessary for survival and neuronal differentiation of our clinical cell candidate therapy for…

Continue ReadingSimplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury

Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells

  • Post author:
  • Post category:

Research Objective We are developing a durable patient-specific dopamine neuron replacement therapy for Parkinson's disease Impact Parkinson's disease is diagnosed when half of the dopamine (DA) neurons are lost from…

Continue ReadingAutologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells

Human induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury

  • Post author:
  • Post category:

Research Objective Allogeneic human induced pluripotent stem cell-derived glial enriched progenitor cell therapy to treat mild traumatic brain injury Impact Prior to this study, glial cell-based therapies have never been…

Continue ReadingHuman induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury

Inhibitory interneurons derived from human induced pluripotent stem cells to treat stroke

  • Post author:
  • Post category:

Research Objective Allogeneic Human induced pluripotent stem cells-derived inhibitory interneuron therapy product encapsulated in a hyaluronan/VEGF nanoparticle hydrogel for the treatment of stroke Impact Previous stem cell-based technologies had poor…

Continue ReadingInhibitory interneurons derived from human induced pluripotent stem cells to treat stroke

Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)

  • Post author:
  • Post category:

Research Objective The research proposed here will support the development of NGL-101, a cell therapy for treating adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Impact Successful development of…

Continue ReadingGene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)